3.
Characteristics | Univariate | Multivariate | |||||
OR | 95% CI | P | OR | 95% CI | P | ||
CEA, carcinoembryonic antigen; CA, carbohydrate antigen; CXCL14, C-X-C motif chemokine ligand 14; OR, odds ratio; 95% CI, 95% confidence interval. | |||||||
Sex (Female vs. Male) | 1.06 | 0.46−2.45 | 0.89 | 1.04 | 0.35−2.99 | 0.94 | |
Age (<60vs. ≥60) (year) | 1.13 | 0.51−2.49 | 0.76 | 1.24 | 0.43−3.53 | 0.69 | |
Pathology (Poor to Well) | 0.34 | 0.10−1.18 | 0.09 | 2.45 | 0.51−12.56 | 0.32 | |
Tumor size (≥4 vs. <4) (cm) | 1.50 | 0.66−3.40 | 0.34 | 3.10 | 0.49−19.63 | 0.52 | |
Lymph node metastasis (No vs. Yes) | 2.01 | 0.86−4.68 | 0.11 | 1.00 | 0.31−32.76 | 0.99 | |
Stage number (III/IV vs. I/II) | 6.00 | 1.34−26.81 | 0.02 | 0.11 | 0.04−0.30 | 0.94 | |
CEA (Normal vs. High) | 1.41 | 0.60−3.28 | 0.43 | 0.32 | 0.08−3.02 | 0.78 | |
CA 19-9 (Normal vs. High) | 1.25 | 0.47−3.36 | 0.65 | 0.14 | 0.03−0.72 | 0.02 | |
CA 72-4 (Normal vs. High) | 6.90 | 2.14−22.24 | 0.01 | 2.35 | 1.54−5.97 | 0.04 | |
CXCL14 (Low vs. High) (Negative) | 2.13 | 1.51−3.49 | 0.04 | 1.24 | 0.43−3.53 | 0.03 |